al., propose two mechanisms, possibly countering the tRF-2-mediated tumor-suppressive mechanism: avoidance of the hypoxia-evoked induction of tumor-suppressive tRFs and the upregulation of YBX1 [181]. The gene discussed is YBX1; the disease is neoplasm.